Rapid colorimetric assay for the quantification of leukemia inhibitory factor (LIF) and interleukin-6 (IL-6)

Area of Science:

• Biochemistry
• Cell Biology
• Assay Development

Background:

• Traditional methods for quantifying leukemia inhibitory factor (LIF) activity rely on measuring M1 cell proliferation suppression or phagocytic activity stimulation.
• These established assays can be time-consuming and may lack optimal sensitivity for certain applications.

Purpose of the Study:

• To develop and validate a novel, rapid, and sensitive assay for quantifying leukemia inhibitory factor (LIF) activity.
• To explore the utility of the developed assay for quantifying other related cytokines, such as IL-6.

Main Methods:

• Development of a new assay based on measuring MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) reduction by mouse myelocytic leukemia (M1) cells.
• Correlation analysis between MTT reduction levels and varying concentrations of LIF used for M1 cell stimulation.

Main Results:

• M1 cell MTT reduction demonstrated a clear correlation with the level of LIF stimulation.
• The novel MTT assay proved to be significantly faster than existing methods for LIF quantification.
• The assay exhibited comparable sensitivity to traditional methods, ensuring reliable quantification.

Conclusions:

• The MTT reduction assay provides a rapid, sensitive, and reliable method for quantifying leukemia inhibitory factor (LIF) activity.
• This novel assay is a valuable alternative to conventional methods, offering improved efficiency.
• The MTT assay's versatility allows for the quantification of other cytokines, including IL-6.